Scotts Miracle-gro CO Form 4 insider transactions

Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reports acquiring additional common shares in a recent transaction.

Nathan Eric Baxter, President and COO of Scotts Miracle-Gro, reports the acquisition of common shares and updates beneficial ownership.

Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports acquisition of common shares and holdings in 401(K) plan.

James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports acquiring additional common shares through a transaction on March 25, 2025.

James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, settled phantom stock units for common shares and reported changes in beneficial ownership on April 3, 2025.

Director Stephen L. Johnson acquired 263 common shares of Scotts Miracle-Gro Co. through deferred stock units on April 1, 2025.

Director Brian E. Sandoval acquired 525 common shares of Scotts Miracle-Gro Co. on April 1, 2025, at a price of $54.77 per share.

James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports acquiring phantom stock representing the right to receive common shares or their cash value.

Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports acquisition of phantom stock convertible to common shares.

Director Roberto Candelino reports acquisition of dividend equivalent rights convertible to 35 common shares of Scotts Miracle-Gro Co.

Director Brian E. Sandoval reports acquiring dividend equivalent rights convertible to 144 common shares of Scotts Miracle-Gro on March 7, 2025.

Director Edith Aviles reports acquiring dividend equivalent rights related to Scotts Miracle-Gro shares.

Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reports several transactions increasing his beneficial ownership of company stock.

Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports several transactions involving common shares and derivative securities.

Director Adam Hanft reports acquiring dividend equivalent rights related to Scotts Miracle-Gro shares.

Director Mark D. Kingdon reports acquisition of dividend equivalent rights tied to Scotts Miracle-Gro common shares.

James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports transactions involving common shares and phantom stock.

Director John R. Vines reports acquiring dividend equivalent rights related to Scotts Miracle-Gro shares.

Director Peter Shumlin reports acquiring dividend equivalent rights convertible to 157 common shares of Scotts Miracle-Gro Co. on March 7, 2025.

Director David C. Evans reports acquiring 102 dividend equivalent rights related to existing DSU or RSU grants.

Nathan Baxter, President and COO of Scotts Miracle-Gro, reports transactions involving the company's common shares, including acquisitions at prices of $61.64, $50.74 and $63.0377.

Director Nick Miaritis reports acquiring 31 dividend equivalent rights related to Scotts Miracle-Gro common shares on March 7, 2025.

Director Stephen L. Johnson reported acquiring 126 dividend equivalent rights related to Scotts Miracle-Gro shares on March 7, 2025.

Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, reports acquisition of phantom stock convertible to common shares.

James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports acquiring phantom stock representing the right to receive common shares or their cash value.

Hagedorn Partnership, L.P., along with several related individuals, reported the sale of Scotts Miracle-Gro Co common shares on February 13, 2025.

Director Brian E. Sandoval reported selling 1,513 common shares of Scotts Miracle-Gro Co. on February 12, 2025, at a weighted average price of $65.8596.

Executives and the Hagedorn Partnership reported changes in their beneficial ownership of Scotts Miracle-Gro Co. common shares following a transaction on February 7, 2025.

John R. Vines, a director at Scotts Miracle-Gro, amended a previous Form 4 filing to correct the number of shares acquired on January 31, 2025.

Brian E. Sandoval, a director at Scotts Miracle-Gro, filed an amended Form 4 to correct the number of shares acquired in recent transactions.